AXL/Angiokinase-IN-1 (compound 11b) is an inhibitor of AXL/triple angiokinase, with an IC50 of 3.75 nM for AXL expression. This compound suppresses epithelial-mesenchymal transition (EMT) in Bxpc-3 cells and prevents metastasis in lung cancer cells. Additionally, AXL/Angiokinase-IN-1 impairs the functions of vascular and fibroblast cells and induces apoptosis in both cancer and fibroblast cells. It is characterized by low toxicity and favorable metabolic stability.
Molecular Weight:
544.09
Formula:
C31H34ClN5O2
Target:
PDGFR|||FGFR|||Apoptosis|||VEGFR
* VAT and and shipping costs not included. Errors and price changes excepted
